At an estimated value of over USD 4.02 billion in 2021, the Global Peripheral Artery Disease Market is predicted to thrive at a CAGR of 7.5% and valued at over USD 7.80 billion over the forecast year 2022-2030. Peripheral artery disease is a common circulatory problem that causes narrowing of the peripheral arteries. Generally, it affects arteries in the legs and sometimes affects the arteries carrying blood from the heart to the arms, kidneys, head, and stomach. It is mainly caused by the deposition of fats or plaques in the artery walls. Exercise, tobacco cessation, and a healthy diet are the main treatments for this disease; however, when such treatments aren't enough, medication or surgery can be helpful.
Factors such as the huge geriatric population, widespread unhealthy lifestyle choices, and rise in new product approvals in the field of peripheral artery disease drive the growth of the market. In addition, high-risk factors including diabetes and smoking contribute to the upsurged incidences of peripheral arterial diseases, further propelling the market growth. However, the concern of restenosis and the reoccurrence of peripheral artery disease (PAD) even after the treatment may hamper the growth of the market to some extent. On the other hand, continually changing lifestyle habits including unhealthy dietary habits, excessive alcohol consumption, and lack of physical activity also make people more vulnerable to PAD and thus, boost the market growth.
The global peripheral artery disease market share is segmented on the basis of type, and geography. On the basis of type, the market is segmented into peripheral angioplasty balloons, peripheral catheters, inferior vena cava (IVC) filters, peripheral stents, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. Geographic fragmentation and analysis of each segment include regions comprising North America, Europe, Asia Pacific, and RoW.
In terms of geography, North America held the major share of the market in 2019. This is attributed to higher healthcare expenditure and the growing occurrence of minimally invasive surgeries in the region. However, Asia-pacific is expected to be the fastest-growing market due to the existence of a large patient pool along with unmet medical needs. Moreover, significant growth in population together with a growing geriatric population is expected to be opportunistic for the market growth in this region during the forecast period.
Global Peripheral Artery Disease Market – By Geography
Market Dynamics and Trends
Factors such as the huge geriatric population, widespread unhealthy lifestyle choices, and rise in new product approvals in the field of peripheral artery disease drive the growth of the market. In addition, high-risk factors including diabetes and smoking contribute to the upsurged incidences of peripheral arterial diseases, further propelling the market growth. However, the concern of restenosis and the reoccurrence of peripheral artery disease (PAD) even after the treatment may hamper the growth of the market to some extent. On the other hand, continually changing lifestyle habits including unhealthy dietary habits, excessive alcohol consumption, and lack of physical activity also make people more vulnerable to PAD and thus, boost the market growth.
Market Segmentations and Scope of the Study:
The global peripheral artery disease market share is segmented on the basis of type, and geography. On the basis of type, the market is segmented into peripheral angioplasty balloons, peripheral catheters, inferior vena cava (IVC) filters, peripheral stents, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. Geographic fragmentation and analysis of each segment include regions comprising North America, Europe, Asia Pacific, and RoW.
Geographical Analysis
In terms of geography, North America held the major share of the market in 2019. This is attributed to higher healthcare expenditure and the growing occurrence of minimally invasive surgeries in the region. However, Asia-pacific is expected to be the fastest-growing market due to the existence of a large patient pool along with unmet medical needs. Moreover, significant growth in population together with a growing geriatric population is expected to be opportunistic for the market growth in this region during the forecast period.Competitive Landscape
Lucrative growth opportunities make the peripheral artery disease market highly competitive. Some of the major players in the market are Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc., Terumo Corporation, Cook Medical, Becton, Dickinson and Company, Koninklijke Philips N.V, AngioDynamics, Inc., BIOTRONIK, and B. Braun Melsungen AG. and many more. A number of developmental strategies have been adopted by companies in the past few years. For instance, in September 2020, Abbott Laboratories started the LIFE-BTK clinical trial to assess the effectiveness and safety of its Esprit BTK Everolimus-Eluting Resorbable Scaffold System. This is the Investigational Device Exemption (IDE) trial in the U.S. that is expected to help people battling the advanced stages of peripheral artery disease (PAD). Also, in June 2020, Becton, Dickinson and Company acquired Straub Medical AG, a private company. Straub Medical AG develops medical atherectomy & thrombectomy devices for the treatment of venous disease and peripheral arterial disease (PAD). This acquisition strengthens peripheral artery disease treatment capabilities of the Becton, Dickinson and Company.Key Market Segments
Global Peripheral Artery Disease Market– By Type- Peripheral Angioplasty Balloons
- Old/Normal Balloons
- Cutting and Scoring Balloons
- Drug-Coated Balloons
- Peripheral Stents
- Self-expandable
- Balloon-expandable
- Covered
- Drug-eluting Stents
- Peripheral Catheters
- Angiography Catheters
- Guiding Catheters
- Inferior Vena Cava (IVC) Filters
- Permanent Filters
- Retrievable Filters
- Plaque Modification Devices
- Thrombectomy Devices
- Atherectomy Devices
- Hemodynamic Flow Alteration Devices
- Embolic Protection Devices
- Chronic Total Occlusion Devices
- Peripheral Accessories
- Peripheral Vascular Closure Devices
- Introducer Sheaths
- Guidewires
- Balloon Inflation Devices
Global Peripheral Artery Disease Market – By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
- RoW
- Brazil
- Saudi Arabia
- South Africa
- Remaining Countries
Table of Contents
1. Introduction
2. Peripheral Artery Disease Devices Market – Executive Summary
3. Market Overview
4. Global Peripheral Artery Disease (Pad) Devices Market, By Type
5. Global Peripheral Artery Disease (Pad) Devices Market, By Region
Executive Summary
Peripheral Artery Disease: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2020 - 2030. Huge geriatric population, widespread unhealthy lifestyle choices, and rise in new products approvals in the field of peripheral artery disease drive the growth of the peripheral artery disease market.Peripheral artery disease is a common circulatory problem that causes narrowing of the peripheral arteries. Generally, it affects arteries in the legs and sometimes affect the arteries carrying blood from heart to arms, kidneys, head, and stomach. It is mainly caused by the deposition of fats or plaques in the artery walls. High risk factors including diabetes and smoking contributes to the upsurged incidences of peripheral arterial diseases, further propelling the market growth. However, the concern of restenosis, the reoccurrence of peripheral artery disease (PAD) even after the treatment may hamper growth of the market to some extent.
The global peripheral artery disease market share is segmented on the basis of type, and geography. On the basis of type, the market is segmented into peripheral angioplasty balloons, peripheral catheters, inferior vena cava (IVC) filters, peripheral stents, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Terumo Corporation
- Cook Medical
- Becton, Dickinson and Company
- Koninklijke Philips N.V
- AngioDynamics, Inc.
- BIOTRONIK,
- B. Braun Melsungen AG.